» Authors » V Paradis

V Paradis

Explore the profile of V Paradis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 88
Citations 1484
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paradis V
Ann Pathol . 2022 Dec; 42(6S):6S3-6S4. PMID: 36577540
No abstract available.
2.
Evrard D, Hourseau M, Couvelard A, Paradis V, Gauthier H, Raymond E, et al.
Oncoimmunology . 2020 Dec; 9(1):1844403. PMID: 33299655
In head and neck squamous cell carcinoma (HNSCC), data from studies using checkpoint-inhibiting antibodies that target programmed death 1 (PD-1) or its ligand the programmed death ligand 1 (PD-L1) demonstrated...
3.
Reizine E, Ronot M, Ghosn M, Calderaro J, Frulio N, Bioulac-Sage P, et al.
Eur Radiol . 2020 Nov; 31(5):3417-3426. PMID: 33146794
Objectives: To assess the value of hepatospecific MR contrast agent uptake on hepatobiliary phase (HBP) images to detect marked activation of the β-catenin pathway in hepatocellular adenomas (HCAs). Methods: This...
4.
Hobeika C, Cauchy F, Sartoris R, Beaufrere A, Yoh T, Vilgrain V, et al.
Br J Surg . 2020 Mar; 107(7):878-888. PMID: 32118298
Background: Quantification of liver surface nodularity (LSN) on routine preoperative CT images allows detection of cirrhosis and clinically significant portal hypertension. This study aimed to assess the relevance of LSN...
5.
Hobeika C, Ronot M, Beaufrere A, Paradis V, Soubrane O, Cauchy F
J Visc Surg . 2019 Dec; 157(3):231-238. PMID: 31866269
In Europe, the prevalence of metabolic syndrome (MS) has reached the endemic rate of 25%. Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of MS. Its definition is histological,...
6.
Paradis V, Quaglia A
J Hepatol . 2019 Mar; 70(5):1016-1018. PMID: 30857782
No abstract available.
7.
Schmitt C, Lenglet H, Yu A, Delaby C, Benecke A, Lefebvre T, et al.
J Intern Med . 2018 Mar; 284(1):78-91. PMID: 29498764
Background: Acute intermittent porphyria (AIP) is an inherited disorder of haem metabolism characterized by life-threatening acute neurovisceral attacks due to the induction of hepatic δ-aminolevulinic acid synthase 1 (ALAS1) associated...
8.
Pupulim L, Ronot M, Paradis V, Chemouny S, Vilgrain V
Diagn Interv Imaging . 2017 Dec; 99(2):83-89. PMID: 29221936
Purpose: The purpose of this study was to assess the accuracy of liver tumor volumetry by manual contouring on computed tomography (CT) compared to pathological tumor volume determined from surgical...
9.
Cros J, Hentic O, Rebours V, Zappa M, Gille N, Theou-Anton N, et al.
Endocr Relat Cancer . 2016 Jun; 23(8):625-33. PMID: 27353036
Temozolomide (TEM) showed encouraging results in well-differentiated pancreatic neuroendocrine tumors (WDPNETs). Low O(6)-methylguanine-DNA methyltransferase (MGMT) expression and MGMT promoter methylation within tumors correlate with a better outcome under TEM-based chemotherapy...
10.
Fuks D, Voitot H, Paradis V, Belghiti J, Vilgrain V, Farges O
Br J Surg . 2014 Jan; 101(4):408-16. PMID: 24477793
Background: Imaging occasionally fails to differentiate hepatic simple cysts from malignant or premalignant mucinous cystic lesions such as biliary cystadenomas. Hepatic simple cysts can be treated conservatively, whereas malignant or...